Christian Kurts elected deputy senator of the Leopoldina

Christian Kurts has been elected deputy senator of the German National Academy of Sciences Leopoldina, section microbiology and immunology.

Congratulation to this success.

Related news

News categories: Honors & Funding

ImmunoSensation goes into the next round

22 May 2025 —The Bonn Cluster of Excellence ImmunoSensation will be funded for further seven years as part of the Excellence Strategy of the German federal and state governments. The aim of the new funding period, which begins on January 1, 2026, is to research immune diversity: the structural, functional and dynamic diversity of the immune system. Involved are the University of Bonn, the University Hospital Bonn (UKB) and the German Center for Neurodegenerative Diseases (DZNE). The funding amounts to around 50 million euros.

View entry

News categories: Honors & Funding

Genome data to improve diagnosis and treatment of long Covid

10 Apr 2025 —Despite the many advances, there are still major gaps in the care of patients with long-term and post-COVID. The Institute of Human Genetics at the UKB in Bonn now begins a genomLC study as part of a BMG funding priority. The researchers want to help speed up the diagnosis of long- and post-COVID and identify possible biomarkers that could possibly also differentiate between subgroups of the diseases. To this end, the genomic data of those affected is being analyzed as part of a study using blood samples. The project is funded by the Federal Ministry of Health (BMG) with 1.34 million euros.

View entry

News categories: Honors & Funding

Creating Personalized Cancer Treatments

24 Feb 2025 —Bonn researchers aim to improve colon cancer treatment using 3D organoids and digital twins. Funded by the Federal Ministry of Education and Research (BMBF), a collaborative project involving the University of Bonn, the company ESQlabs and the University Hospital Bonn is seeking to refine the therapy recommendations given to colon cancer patients. To this end, “ISPOT-K” is merging organoids taken from patients with the power of digital twin technology.

View entry

Back to the news overview